Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Linoleic Acid: Membrane Lipid to Metabolic Signal
2026-10-03
Linoleic Acid, or C18:2(9Z,12Z), is more than a membrane component or oxidative-stress reagent. This evidence-led analysis connects its redox, biophysical, and metabolic roles to recent findings on fatty-acid signaling and selective translation while defining important limits for interpreting research models.
-
OTUD3–SLC7A11 Axis in Sunitinib Resistance
2026-10-02
The reference study identifies OTUD3-mediated deubiquitination of SLC7A11 as a mechanistic driver of sunitinib resistance in clear cell renal cell carcinoma. By preserving cystine uptake, glutathione production, and redox protection, the OTUD3–SLC7A11 axis suppresses lipid peroxidation and ferroptosis, suggesting a rationale for restoring ferroptotic sensitivity during treatment.
-
Annexin V-Cy5/DAPI Apoptosis Kit Workflow
2026-10-01
Build a rapid cell-death workflow that separates viable, early apoptotic, late apoptotic, and necrotic populations in one assay. The approach is especially useful for connecting drug-response phenotypes with the calcium, mitochondrial, and PI3K/Akt findings reported in Ph+ ALL research.
-
Dual HER2–VEGFR2 Targeting in TNBC
2026-10-01
A 2026 study examined lapatinib and Telatinib in HER2-negative MDA-MB-231 triple-negative breast cancer cells, linking combined kinase inhibition with reduced proliferation, invadopodia formation, and two-dimensional angiogenic tube formation. The work provides a phenotype-centered rationale for dual-pathway investigation while leaving target engagement, pharmacological synergy, and in vivo relevance unresolved.
-
Acetylcholine Chloride in Gut-Brain Circuit Science
2026-09-30
Acetylcholine Chloride provides a chemically defined reference point for studying how gut-derived signals engage cholinergic circuits. This article translates recent Bacteroides fragilis findings into a compartment-aware framework for interpreting receptor, vagal, and seizure-related data without mistaking direct acetylcholine exposure for microbiota-mediated physiology.
-
Gene-Modulating Therapies for ATTR Cardiomyopathy
2026-09-30
This 2025 mini-review explains how siRNA, antisense oligonucleotides, and CRISPR-Cas9 move transthyretin amyloid cardiomyopathy treatment from protein stabilization toward suppression or permanent disruption of hepatic TTR production. Its practical contribution is a mechanism-to-clinical-evidence framework that clarifies therapeutic promise while emphasizing unresolved questions about durability, safety, and comparative effectiveness.
-
In Vitro Drug Response Metrics in Cancer Research
2026-09-29
Hannah R. Schwartz’s dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. Its central contribution is a framework for separating growth inhibition from cell killing, improving interpretation of response kinetics and the design of in vitro oncology experiments.
-
AMG 9810: Selective TRPV1 Antagonist Guide
2026-09-29
AMG 9810 is a competitive TRPV1 antagonist that blocks capsaicin-, proton-, heat-, and endogenous-ligand responses. Its nanomolar activity in human and rat TRPV1 systems supports inhibition of capsaicin-induced calcium influx, CGRP release inhibition assays, sensory neuron signaling studies, and pain mechanism research.
-
Dual Luciferase Reporter Gene System for Wnt Studies
2026-09-28
Use a normalized firefly–Renilla readout to distinguish pathway-driven transcription from well-to-well variation, with a lysis-free workflow suited to mammalian cells and screening. The system provides a practical way to extend the CENPI–Wnt/β-catenin findings into promoter, enhancer, and perturbation experiments.
-
Doxycycline in MMP-Responsive Cancer Research
2026-09-28
Use Doxycycline as a research probe to test how broad metalloproteinase inhibition affects enzyme-responsive cancer models—not as a stand-in for the anticancer drugs in the featured study. This workflow emphasizes matched controls, short-term dosing, and separate enzyme and cell readouts to help distinguish MMP-related effects from doxycycline’s own antiproliferative activity.
-
Sulfo-NHS-SS-Biotin for AML Surface Target Studies
2026-09-27
Sulfo-NHS-SS-Biotin offers a cleavable route to capture cell-surface proteins, but its value depends on how labeling results are interpreted. This article connects its chemistry to emerging AML surface-target research and outlines assay choices, controls, and limitations.
-
EdU Imaging Kits (488): Reading Proliferation in HCC
2026-09-26
EdU Imaging Kits (488) measure DNA synthesis during S phase, but their value extends beyond counting proliferating cells. This article shows how 5-ethynyl-2'-deoxyuridine can provide a functional readout for testing cancer-cell phenotypes suggested by hepatocellular carcinoma research—and explains what that readout can and cannot establish.
-
Procainamide Hydrochloride and Cisplatin Liver Protection
2026-09-25
Procainamide Hydrochloride is more than a cardiac sodium channel blocker: rat evidence links it to reduced cisplatin-associated liver injury alongside changes in platinum distribution. This article examines the finding’s mechanistic limits and what it means for designing chemoprotection assays.
-
G-Quadruplexes Shape TDP-43 Condensation and Toxicity
2026-09-25
Oldani et al. show that G-quadruplexes can alter TDP-43 aggregation, cellular distribution, and toxicity across biochemical and cellular models. The findings support investigating RNA structure as a modifier of protein condensation, while leaving open which G-quadruplex populations and ligands can be targeted safely and selectively.
-
EdU Imaging Kits (488): Reading Cell-Cycle Arrest
2026-09-24
EdU Imaging Kits (488) reveal DNA synthesis during S phase, but interpreting a reduced signal requires more than counting fluorescent nuclei. This guide connects EdU readouts to cell-cycle arrest and senescence in NSCLC research, with practical guidance on assay design and interpretation.